BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8099290)

  • 21. [The problem of drug compliance in schizophrenic patients].
    Albus M
    Psychiatr Prax; 1995 Nov; 22(6):221-2. PubMed ID: 8570750
    [No Abstract]   [Full Text] [Related]  

  • 22. Exacerbation of schizophrenia associated with amantadine.
    Nestelbaum Z; Siris SG; Rifkin A; Klar H; Reardon GT
    Am J Psychiatry; 1986 Sep; 143(9):1170-1. PubMed ID: 2875665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Switch or stay?
    Davis JM; Marder SR; Tamminga CA
    Am J Psychiatry; 2006 Dec; 163(12):2032-3. PubMed ID: 17151147
    [No Abstract]   [Full Text] [Related]  

  • 24. Psychopharmacologic treatment of schizophrenia.
    Kane JM; Marder SR
    Schizophr Bull; 1993; 19(2):287-302. PubMed ID: 8100642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depot neuroleptics: the relevance of psychosocial factors--a United States perspective.
    Hogarty GE
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):36-42. PubMed ID: 6143746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of schizophrenia from the viewpoint of the patient. Studies on the course of treatment and neuroleptic treatment from a personal perspective].
    Windgassen K
    Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1989; 58():1-169. PubMed ID: 2576099
    [No Abstract]   [Full Text] [Related]  

  • 27. Electroencephalography in schizophrenic patients: comparison between neuroleptic-naive state and after treatment.
    Nagase Y; Okubo Y; Toru M
    Biol Psychiatry; 1996 Sep; 40(6):452-6. PubMed ID: 8879464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Idiosyncratic neuroleptic response.
    Harrop DS
    J Clin Psychiatry; 1987 Aug; 48(8):344-5. PubMed ID: 2886492
    [No Abstract]   [Full Text] [Related]  

  • 29. Neuroleptic drugs and the prevention of relapse in schizophrenia: a workshop report.
    Hartmann W; Kind J; Meyer JE; Müller P; Steuber H
    Schizophr Bull; 1980; 6(3):536-43. PubMed ID: 6105708
    [No Abstract]   [Full Text] [Related]  

  • 30. [Changes in the health state of schizophrenic patients in neuroleptic therapy].
    Heim M
    Psychiatr Neurol Med Psychol (Leipz); 1986 Aug; 38(8):483-7. PubMed ID: 2878452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroleptic malignant syndrome associated with risperidone long-acting injection: a case report.
    Yamashita T; Fujii Y; Misawa F
    J Clin Psychopharmacol; 2013 Feb; 33(1):127-9. PubMed ID: 23288234
    [No Abstract]   [Full Text] [Related]  

  • 32. Supersensitivity psychosis.
    Peet M
    J Clin Psychiatry; 1991 Feb; 52(2):90. PubMed ID: 1671568
    [No Abstract]   [Full Text] [Related]  

  • 33. Worsened agitation and confusion in schizophrenia subsequent to high-dose aripiprazole.
    Thone J
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):481-2. PubMed ID: 18070865
    [No Abstract]   [Full Text] [Related]  

  • 34. [Discontinuation of antipsychotic drugs in chronic schizophrenic patients. II. Psychological and psychopathological test differences between patients with and without relapse].
    Woggon B; Bickel P; Schnyder B
    Int Pharmacopsychiatry; 1979; 14(5):278-93. PubMed ID: 43849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological treatment of schizophrenia.
    Leucht S; Heres S; Kissling W; Davis JM
    Fortschr Neurol Psychiatr; 2013 May; 81(5):e1-13. PubMed ID: 23702802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zotepine, a neuroleptic drug with a bipolar therapeutic profile.
    Dieterle DM; Ackenheil M; Müller-Spahn F; Kapfhammer HP
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):52-7. PubMed ID: 2883683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depot neuroleptic therapy: clinical considerations.
    Remington GJ; Adams ME
    Can J Psychiatry; 1995 Apr; 40(3 Suppl 1):S5-11. PubMed ID: 7627927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
    Faraone SV; Brown WA; Laughren TP
    J Clin Psychiatry; 1987 Apr; 48(4):151-4. PubMed ID: 2881923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neuroleptic disinhibitory agents].
    Ginestet D
    Encephale; 1978; 4(5 Suppl):541-5. PubMed ID: 38105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.
    Kopala LC; Fredrikson D; Good KP; Honer WG
    Biol Psychiatry; 1996 Feb; 39(4):296-8. PubMed ID: 8645777
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.